1. Home
  2. BLDP vs MYGN Comparison

BLDP vs MYGN Comparison

Compare BLDP & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ballard Power Systems Inc.

BLDP

Ballard Power Systems Inc.

HOLD

Current Price

$2.37

Market Cap

592.5M

Sector

Energy

ML Signal

HOLD

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

HOLD

Current Price

$4.66

Market Cap

481.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLDP
MYGN
Founded
1979
1991
Country
Canada
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
592.5M
481.6M
IPO Year
2009
1996

Fundamental Metrics

Financial Performance
Metric
BLDP
MYGN
Price
$2.37
$4.66
Analyst Decision
Sell
Buy
Analyst Count
7
8
Target Price
$2.24
$7.64
AVG Volume (30 Days)
2.7M
1.5M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$771,400,000.00
Revenue This Year
$41.84
$7.19
Revenue Next Year
$14.68
$5.64
P/E Ratio
N/A
N/A
Revenue Growth
N/A
2.33
52 Week Low
$1.00
$3.76
52 Week High
$4.10
$10.32

Technical Indicators

Market Signals
Indicator
BLDP
MYGN
Relative Strength Index (RSI) 58.73 41.35
Support Level $1.79 $3.93
Resistance Level $2.92 $5.63
Average True Range (ATR) 0.13 0.42
MACD 0.05 0.04
Stochastic Oscillator 64.49 21.43

Price Performance

Historical Comparison
BLDP
MYGN

About BLDP Ballard Power Systems Inc.

Ballard Power Systems Inc is engaged in design, development, manufacture, sale and service of proton exchange membrane ("PEM") fuel cell products for a variety of applications, focusing on power products for bus, truck, rail, marine, stationary and emerging market (material handling, off-road and other) applications, as well as the delivery of services, including technology solutions, after sales services and training. A fuel cell is an environmentally clean electrochemical device that combines hydrogen fuel with oxygen (from the air) to produce electricity. Key geographical revenue is derived from Poland followed by United States, United Kingdom, and other countries.

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.

Share on Social Networks: